Optimal use of raltegravir (Isentress®) in the treatment of HIV-infected adults – Canadian consensus guidelines
AUTOR(ES)
Rachlis, Anita
FONTE
Pulsus Group Inc
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2770304Documentos Relacionados
- Canadian consensus guidelines for the optimal use of etravirine in the treatment of HIV-infected adults
- Facial botryomycosis-like pyoderma in an HIV-infected patient: remission after initiation of darunavir and raltegravir
- Aphthous ulcers in HIV-infected patients: treatment with thalidomide.
- Dyslipidemia in HIV-infected individuals
- CD8 naive T cell counts decrease progressively in HIV-infected adults.